0 results for 'Novo Nordisk'
Civil RICO Suit Accuses Big Pharma and Benefit Managers of Insulin Price-Fixing
"Rather than working to lower insulin and other Type 2 diabetes medication prices, major [pharmacy benefit managers] and manufacturers use their dominant market positions to drastically increase the price of these necessary, life-saving medications, generating billions of dollars in illicit profits," co-lead counsel for the plaintiff claimed in a joint statement.US Judge Ends Antitrust Claim Alleging Conspiracy to Manipulate Prices of Insulin Products
Chief Judge Elizabeth Wolford of U.S. District Court, Western District in Rochester wrote that the plaintiffs failed to present a viable claim under the Sherman Act.'10's of Billions at Stake': Insulin Case Gets OK with Miami Attorney in Lead
"This is a case that goes back 20 years, so the damages are substantial," said the Miami attorney representing the MDLLitigation Leaders: Axinn's Denise Plunkett on the Value of Being Right-Sized and Focused
"The size of our firm puts us in a sweet spot in which we have the diversity of experience and brute-force ability to handle the largest and most complex matters, while also being free of the institutional inertia that plagues larger firms."A Panel Just Consolidated an Insulin MDL—Meet the Lawyers Leading the Charge
"This may turn into one of the most significant cases in recent history," attorney Benjamin J. Widlanski said.View more book results for the query "Novo Nordisk"
Eli Lilly's Insulin Price Cut Not Likely to Extricate It From Legal Morass
"If a company has acquired or maintained monopoly power through anticompetitive means, they're liable under the antitrust laws whether or not they're exploiting their monopoly power by charging monopoly prices," said Daniel Crane, a professor at the University of Michigan Law School.Price-Fixing Claims Pressed in Novo Nordisk Shareholder Suits
Danish drugmaker Novo Nordisk is facing two shareholder class actions in federal court accusing it of inflating its earning prospects and engaging in collusive pricing of its insulin drugs for diabetics.Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now
Practical Guidance Journal: Protecting Work Product in a Generative AI World
Brought to you by LexisNexis®
Download Now
Countdown to Compliance: SEC Private Fund Reforms
Brought to you by Ontra
Download Now